• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于删失生存数据评估风险预测方法整体充分性的 C 统计量。

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

机构信息

Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, MA, USA.

出版信息

Stat Med. 2011 May 10;30(10):1105-17. doi: 10.1002/sim.4154. Epub 2011 Jan 13.

DOI:10.1002/sim.4154
PMID:21484848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3079915/
Abstract

For modern evidence-based medicine, a well thought-out risk scoring system for predicting the occurrence of a clinical event plays an important role in selecting prevention and treatment strategies. Such an index system is often established based on the subject's 'baseline' genetic or clinical markers via a working parametric or semi-parametric model. To evaluate the adequacy of such a system, C-statistics are routinely used in the medical literature to quantify the capacity of the estimated risk score in discriminating among subjects with different event times. The C-statistic provides a global assessment of a fitted survival model for the continuous event time rather than focussing on the prediction of bit-year survival for a fixed time. When the event time is possibly censored, however, the population parameters corresponding to the commonly used C-statistics may depend on the study-specific censoring distribution. In this article, we present a simple C-statistic without this shortcoming. The new procedure consistently estimates a conventional concordance measure which is free of censoring. We provide a large sample approximation to the distribution of this estimator for making inferences about the concordance measure. Results from numerical studies suggest that the new procedure performs well in finite sample.

摘要

对于现代循证医学,一个精心设计的风险评分系统对于预测临床事件的发生起着重要作用,有助于选择预防和治疗策略。这样的指标体系通常是基于研究对象的“基线”遗传或临床标志物,通过工作参数或半参数模型建立的。为了评估该系统的充分性,C 统计量在医学文献中被常规用于量化估计风险评分在区分不同事件时间的研究对象方面的能力。C 统计量为拟合生存模型提供了对连续事件时间的整体评估,而不是专注于固定时间的位年生存率预测。然而,当事件时间可能被删失时,通常使用的 C 统计量所对应的总体参数可能取决于研究特定的删失分布。在本文中,我们提出了一种简单的 C 统计量,没有这种缺点。新方法一致地估计了一种常规的一致性度量,该度量不受删失的影响。我们提供了一个大样本逼近这个估计量的分布,以便对一致性度量进行推断。数值研究的结果表明,新方法在有限样本中表现良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc21/3079915/49a185691af4/nihms255748f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc21/3079915/7acff32db513/nihms255748f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc21/3079915/49a185691af4/nihms255748f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc21/3079915/7acff32db513/nihms255748f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc21/3079915/49a185691af4/nihms255748f2.jpg

相似文献

1
On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.基于删失生存数据评估风险预测方法整体充分性的 C 统计量。
Stat Med. 2011 May 10;30(10):1105-17. doi: 10.1002/sim.4154. Epub 2011 Jan 13.
2
On comparing 2 correlated C indices with censored survival data.比较两个具有删失生存数据的相关C指数。
Stat Med. 2017 Nov 10;36(25):4041-4049. doi: 10.1002/sim.7414. Epub 2017 Jul 31.
3
Concordance indices with left-truncated and right-censored data.一致性指数与左截断和右删失数据。
Biometrics. 2023 Sep;79(3):1624-1634. doi: 10.1111/biom.13714. Epub 2022 Jul 11.
4
Estimating subject-specific dependent competing risk profile with censored event time observations.利用删失事件时间观测估计特定个体的相依竞争风险概况。
Biometrics. 2011 Jun;67(2):427-35. doi: 10.1111/j.1541-0420.2010.01456.x. Epub 2010 Jul 9.
5
Quantifying discrimination of Framingham risk functions with different survival C statistics.用不同生存 C 统计量量化 Framingham 风险函数的判别能力。
Stat Med. 2012 Jul 10;31(15):1543-53. doi: 10.1002/sim.4508. Epub 2012 Feb 17.
6
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event-Moving Beyond C Statistic: A Review.量化和解释心血管事件时间模型预测准确性:超越 C 统计量:综述。
JAMA Cardiol. 2023 Mar 1;8(3):290-295. doi: 10.1001/jamacardio.2022.5279.
7
Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar.多种机器学习和统计模型在预测个体患者临床风险方面的一致性:以心血管疾病为例的纵向队列研究
BMJ. 2020 Nov 4;371:m3919. doi: 10.1136/bmj.m3919.
8
Factorial analyses of treatment effects under independent right-censoring.独立右删失情况下治疗效果的因子分析。
Stat Methods Med Res. 2020 Feb;29(2):325-343. doi: 10.1177/0962280219831316. Epub 2019 Mar 5.
9
Investigating the appropriateness of different concordance measures in a time-to-event setting.探讨在生存时间设定下不同一致性测量指标的适宜性。
Pharm Stat. 2020 Nov;19(6):763-775. doi: 10.1002/pst.2029. Epub 2020 May 21.
10
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.

引用本文的文献

1
Bayesian integration of longitudinal and survival outcomes in Alzheimer's disease prediction.贝叶斯方法在阿尔茨海默病预测中对纵向和生存结果的整合
Alzheimers Dement. 2025 Sep;21(9):e70094. doi: 10.1002/alz.70094.
2
Longitudinal structural MRI-based deep learning and radiomics features for predicting Alzheimer's disease progression.基于纵向结构磁共振成像的深度学习和影像组学特征预测阿尔茨海默病进展
Alzheimers Res Ther. 2025 Aug 7;17(1):182. doi: 10.1186/s13195-025-01827-2.
3
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHADS-VASc-Biomarkers model.

本文引用的文献

1
Evaluating subject-level incremental values of new markers for risk classification rule.评估用于风险分类规则的新标志物的个体水平增量值。
Lifetime Data Anal. 2013 Oct;19(4):547-67. doi: 10.1007/s10985-013-9272-6. Epub 2013 Jun 27.
2
On the prognostic value of survival models with application to gene expression signatures.基于生存模型的预后价值及其在基因表达谱中的应用。
Stat Med. 2010 Mar 30;29(7-8):818-29. doi: 10.1002/sim.3768.
3
An updated catalog of prostate cancer predictive tools.前列腺癌预测工具的最新目录。
利用循环生物标志物改善心房颤动患者的卒中风险预测:CHADS-VASc-生物标志物模型
J Thromb Haemost. 2025 Aug 1. doi: 10.1016/j.jtha.2025.06.007.
4
Predicting mortality risk in Alzheimer's disease using machine learning based on lifestyle and physical activity.基于生活方式和身体活动,利用机器学习预测阿尔茨海默病的死亡风险。
Sci Rep. 2025 Jul 24;15(1):26928. doi: 10.1038/s41598-025-11819-9.
5
Long-Term Performance of Prognostic Models for Advanced Renal Cell Carcinoma in the Era of Improved Survival With Immune Checkpoint Inhibitors.免疫检查点抑制剂改善生存时代晚期肾细胞癌预后模型的长期性能
JCO Oncol Pract. 2025 Jul 14:OP2500089. doi: 10.1200/OP-25-00089.
6
Improved prediction of MAPKi response duration in melanoma patients using genomic data and machine learning.利用基因组数据和机器学习改善黑色素瘤患者对MAPK抑制剂反应持续时间的预测
NPJ Precis Oncol. 2025 Jul 9;9(1):231. doi: 10.1038/s41698-025-00814-y.
7
Artificial intelligence unravels interpretable malignancy grades of prostate cancer on histology images.人工智能在组织学图像上解析可解释的前列腺癌恶性等级。
Npj Imaging. 2024 Mar 6;2(1):6. doi: 10.1038/s44303-023-00005-z.
8
Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank.在英国生物银行中使用线性和神经网络模型预测常见疾病的蛋白质组学风险评分。
Sci Rep. 2025 Jul 1;15(1):20520. doi: 10.1038/s41598-025-06232-1.
9
Comparative study of five-year cervical cancer cause-specific survival prediction models based on SEER data.基于监测、流行病学和最终结果(SEER)数据的五年期宫颈癌特定病因生存预测模型的比较研究
Sci Rep. 2025 Jul 2;15(1):22465. doi: 10.1038/s41598-025-04540-0.
10
Trajectory of plasma lipidome associated with the risk of late-onset Alzheimer's disease: a longitudinal cohort study.与晚发型阿尔茨海默病风险相关的血浆脂质组轨迹:一项纵向队列研究。
EBioMedicine. 2025 Jun 30;118:105826. doi: 10.1016/j.ebiom.2025.105826.
Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908.
4
General cardiovascular risk profile for use in primary care: the Framingham Heart Study.用于初级保健的一般心血管风险概况:弗雷明汉心脏研究
Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.
5
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.预测高血压近期发病率的风险评分:弗雷明汉心脏研究
Ann Intern Med. 2008 Jan 15;148(2):102-10. doi: 10.7326/0003-4819-148-2-200801150-00005.
6
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.评估新标志物的附加预测能力:从ROC曲线下面积到重新分类及其他。
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12. doi: 10.1002/sim.2929.
7
Estimation of time-dependent area under the ROC curve for long-term risk prediction.用于长期风险预测的ROC曲线下随时间变化面积的估计。
Stat Med. 2006 Oct 30;25(20):3474-86. doi: 10.1002/sim.2299.
8
The sensitivity and specificity of markers for event times.事件发生时间标志物的敏感性和特异性。
Biostatistics. 2006 Apr;7(2):182-97. doi: 10.1093/biostatistics/kxi047. Epub 2005 Aug 3.
9
Survival model predictive accuracy and ROC curves.生存模型预测准确性和ROC曲线。
Biometrics. 2005 Mar;61(1):92-105. doi: 10.1111/j.0006-341X.2005.030814.x.
10
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.伤口反应基因表达特征在预测乳腺癌生存中的稳健性、可扩展性和整合性。
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43. doi: 10.1073/pnas.0409462102. Epub 2005 Feb 8.